Table 3.
Number of genes | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TF Family | 10 | 18 | 10vs13IR | 18vs11IR | ||||||||||||
0.2 | 0.5 | 0.2 | 0.5 | 0.2 | 0.5 | 0.2 | 0.5 | |||||||||
Up | down | Up | down | Up | down | Up | down | Up | down | Up | down | Up | down | Up | down | |
ABI3VP1 | 12 | 10 | 12 | 9 | 8 | 9 | 10 | 12 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 4 |
Alfin-like | 0 | 3 | 0 | 3 | 0 | 1 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
AP2-EREBP | 25 | 73 | 27 | 60 | 25 | 67 | 25 | 65 | 7 | 3 | 2 | 6 | 5 | 0 | 1 | 6 |
ARF | 10 | 3 | 11 | 4 | 11 | 3 | 10 | 4 | 0 | 0 | 2 | 1 | 0 | 0 | 2 | 0 |
ARID | 2 | 1 | 1 | 0 | 1 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
ARR-B | 1 | 1 | 1 | 2 | 1 | 2 | 2 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
AUX/IAA | 4 | 19 | 5 | 16 | 1 | 17 | 4 | 17 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 |
BBR/BPC | 2 | 0 | 2 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
BES1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
bHLH | 25 | 44 | 23 | 50 | 26 | 48 | 24 | 48 | 3 | 2 | 4 | 5 | 3 | 4 | 3 | 2 |
BSD | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
bZIP | 22 | 32 | 18 | 26 | 20 | 30 | 20 | 25 | 1 | 2 | 2 | 2 | 1 | 1 | 2 | 2 |
C2C2-CO-like | 10 | 3 | 11 | 2 | 9 | 3 | 10 | 1 | 1 | 0 | 3 | 0 | 1 | 0 | 1 | 0 |
C2C2-Dof | 3 | 13 | 4 | 10 | 6 | 10 | 7 | 8 | 1 | 1 | 2 | 1 | 1 | 0 | 3 | 1 |
C2C2-GATA | 7 | 7 | 7 | 5 | 7 | 8 | 5 | 7 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 0 |
C2C2-YABBY | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
C2H2 | 19 | 33 | 21 | 28 | 16 | 31 | 17 | 28 | 5 | 2 | 5 | 5 | 2 | 1 | 1 | 1 |
C3H | 20 | 12 | 13 | 12 | 18 | 9 | 16 | 7 | 0 | 1 | 3 | 3 | 0 | 3 | 3 | 3 |
CAMTA | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CCAAT | 8 | 17 | 4 | 16 | 6 | 13 | 9 | 13 | 0 | 2 | 1 | 3 | 1 | 3 | 3 | 0 |
Coactivator p15 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CPP | 3 | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DBP | 3 | 1 | 3 | 0 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
DDT | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
E2F-DP | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EIL | 5 | 1 | 4 | 1 | 4 | 0 | 4 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
FAR1 | 17 | 3 | 11 | 4 | 16 | 3 | 13 | 1 | 1 | 1 | 2 | 1 | 2 | 1 | 1 | 1 |
FHA | 10 | 4 | 6 | 3 | 5 | 3 | 5 | 2 | 1 | 2 | 3 | 1 | 0 | 0 | 0 | 1 |
G2-like | 11 | 12 | 11 | 9 | 9 | 13 | 10 | 9 | 2 | 0 | 4 | 0 | 0 | 1 | 2 | 0 |
GeBP | 2 | 0 | 3 | 0 | 4 | 0 | 2 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 2 | 0 |
GNAT | 13 | 11 | 10 | 8 | 9 | 9 | 9 | 8 | 4 | 1 | 2 | 1 | 0 | 0 | 1 | 1 |
GRAS | 14 | 16 | 8 | 14 | 12 | 15 | 10 | 19 | 2 | 2 | 3 | 1 | 2 | 2 | 1 | 3 |
GRF | 3 | 4 | 3 | 4 | 3 | 4 | 3 | 4 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 |
HB | 19 | 30 | 18 | 29 | 19 | 27 | 20 | 27 | 1 | 2 | 2 | 5 | 1 | 1 | 1 | 0 |
HMG | 3 | 2 | 2 | 3 | 4 | 2 | 2 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
HSF | 12 | 4 | 11 | 4 | 12 | 5 | 10 | 4 | 0 | 0 | 1 | 2 | 1 | 0 | 1 | 0 |
IWS1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Jumonji | 1 | 5 | 0 | 6 | 0 | 6 | 1 | 6 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
LIM | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
LOB | 5 | 9 | 6 | 10 | 6 | 9 | 2 | 10 | 1 | 0 | 0 | 1 | 2 | 0 | 0 | 0 |
LUG | 2 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
MADS | 7 | 16 | 4 | 13 | 4 | 14 | 6 | 12 | 1 | 3 | 0 | 3 | 0 | 2 | 2 | 1 |
MBF1 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
mTERF | 10 | 3 | 7 | 1 | 9 | 3 | 6 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
MYB | 22 | 35 | 22 | 32 | 21 | 39 | 20 | 38 | 0 | 1 | 4 | 5 | 0 | 0 | 1 | 4 |
MYB-related | 17 | 19 | 13 | 23 | 11 | 19 | 13 | 21 | 1 | 1 | 4 | 1 | 1 | 1 | 3 | 2 |
NAC | 15 | 44 | 20 | 32 | 15 | 44 | 19 | 30 | 1 | 1 | 3 | 3 | 1 | 1 | 3 | 1 |
OFP | 2 | 15 | 2 | 14 | 1 | 14 | 2 | 15 | 2 | 2 | 1 | 5 | 1 | 0 | 0 | 2 |
Orphans | 15 | 20 | 13 | 22 | 13 | 21 | 10 | 24 | 0 | 5 | 3 | 2 | 2 | 4 | 1 | 0 |
PHD | 16 | 6 | 11 | 6 | 13 | 5 | 10 | 6 | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 |
PLATZ | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 1 |
Pseudo ARR-B | 3 | 0 | 3 | 0 | 2 | 0 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RB | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
Rcd1-like | 1 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
RWP-RK | 2 | 1 | 2 | 3 | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
S1Fa-like | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SBP | 4 | 5 | 3 | 6 | 6 | 6 | 5 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
SET | 10 | 3 | 7 | 4 | 8 | 2 | 8 | 4 | 0 | 0 | 5 | 1 | 0 | 0 | 3 | 1 |
Sigma70-like | 5 | 5 | 3 | 0 | 5 | 0 | 5 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 |
SNF2 | 11 | 5 | 6 | 4 | 10 | 4 | 7 | 4 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 1 |
SOH1 | 1 | 0 | 1 | 0 | 2 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 1 | 0 |
SRS | 0 | 0 | 0 | 3 | 0 | 4 | 0 | 4 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 |
SWI/SNF-BAF60b | 1 | 0 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SWI/SNF-SWI3 | 0 | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 |
TAZ | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
TCP | 6 | 6 | 5 | 5 | 6 | 3 | 8 | 5 | 0 | 2 | 1 | 1 | 0 | 0 | 2 | 2 |
Tify | 4 | 7 | 3 | 8 | 1 | 10 | 2 | 9 | 0 | 0 | 0 | 1 | 0 | 3 | 0 | 0 |
TRAF | 6 | 8 | 5 | 10 | 5 | 9 | 7 | 11 | 1 | 0 | 2 | 1 | 1 | 1 | 3 | 0 |
Trihelix | 5 | 6 | 5 | 4 | 6 | 3 | 7 | 3 | 0 | 3 | 2 | 1 | 1 | 1 | 1 | 0 |
TUB | 4 | 4 | 4 | 4 | 3 | 4 | 5 | 2 | 1 | 1 | 2 | 2 | 0 | 0 | 0 | 0 |
WRKY | 13 | 48 | 18 | 38 | 13 | 51 | 15 | 45 | 2 | 3 | 9 | 2 | 4 | 0 | 4 | 1 |
zf-HD | 1 | 3 | 1 | 2 | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 0 |
Total | 487 | 648 | 428 | 588 | 437 | 625 | 434 | 593 | 42 | 49 | 88 | 77 | 39 | 36 | 56 | 47 |
In this table, 10 and 18 are two tolerant NILs (IR77298-14-1-2-B-10 and IR77298-5-6-B-18), 10vs13IR and 18vs11IR are comparisons of DEGs specifically expressed in tolerant NILs against their susceptible counterparts (IR77298-14-1-2-B-10 versus IR77298-14-1-2-B-13 and IR64; and IR77298-5-6-B-18 versus IR77298-5-6-B-11 and IR64), respectively. 0.2 and 0.5 are two FTSW treatments. Up = significantly up-regulated genes, down = significantly down-regulated gen